NO934719L - Hemmere av HIV-protease som er nyttige for behandling av AIDS - Google Patents
Hemmere av HIV-protease som er nyttige for behandling av AIDSInfo
- Publication number
- NO934719L NO934719L NO934719A NO934719A NO934719L NO 934719 L NO934719 L NO 934719L NO 934719 A NO934719 A NO 934719A NO 934719 A NO934719 A NO 934719A NO 934719 L NO934719 L NO 934719L
- Authority
- NO
- Norway
- Prior art keywords
- aids
- inhibitors
- hiv protease
- treatment
- formula
- Prior art date
Links
- 208000030507 AIDS Diseases 0.000 title abstract 2
- 108010010369 HIV Protease Proteins 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000006705 (C5-C7) cycloalkyl group Chemical group 0.000 abstract 1
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
- C07D215/60—N-oxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99525692A | 1992-12-22 | 1992-12-22 | |
| US08/134,329 US5733906A (en) | 1993-10-12 | 1993-10-12 | Inhibitors of HIV Protease useful for the treatment of Aids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO934719D0 NO934719D0 (no) | 1993-12-20 |
| NO934719L true NO934719L (no) | 1994-06-23 |
Family
ID=26832220
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO934719A NO934719L (no) | 1992-12-22 | 1993-12-20 | Hemmere av HIV-protease som er nyttige for behandling av AIDS |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5905077A (OSRAM) |
| EP (1) | EP0604185B1 (OSRAM) |
| JP (1) | JPH06271534A (OSRAM) |
| KR (1) | KR940014337A (OSRAM) |
| CN (1) | CN1044117C (OSRAM) |
| AT (1) | ATE178055T1 (OSRAM) |
| AU (1) | AU667146B2 (OSRAM) |
| BR (1) | BR9305162A (OSRAM) |
| CA (1) | CA2112042A1 (OSRAM) |
| CZ (1) | CZ281493A3 (OSRAM) |
| DE (1) | DE69324120T2 (OSRAM) |
| ES (1) | ES2132201T3 (OSRAM) |
| FI (1) | FI935778A7 (OSRAM) |
| HU (1) | HUT69693A (OSRAM) |
| IL (1) | IL108092A (OSRAM) |
| MX (1) | MX9308016A (OSRAM) |
| MY (1) | MY131388A (OSRAM) |
| NO (1) | NO934719L (OSRAM) |
| NZ (1) | NZ250491A (OSRAM) |
| PL (1) | PL301581A1 (OSRAM) |
| TW (1) | TW262468B (OSRAM) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USH1649H (en) | 1987-07-31 | 1997-05-06 | Barrish; Joel C. | HIV protease inhibitor combinations |
| US5888992A (en) | 1992-03-11 | 1999-03-30 | Narhex Limited | Polar substituted hydrocarbons |
| BR9306058A (pt) | 1992-03-11 | 1997-11-18 | Narhex Ltd | Derivados de amina de hidrocarbonetos oxo- e hidroxi- substituidos |
| US6071895A (en) | 1992-03-11 | 2000-06-06 | Narhex Limited | Polar-substituted hydrocarbons |
| US5484926A (en) | 1993-10-07 | 1996-01-16 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
| US5461154A (en) * | 1994-02-02 | 1995-10-24 | Eli Lilly And Company | Intermediate and process for making |
| TW472047B (en) * | 1994-02-04 | 2002-01-11 | Merck & Co Inc | Process for making HIV protease inhibitors |
| DE69501705T2 (de) * | 1994-11-04 | 1998-06-25 | Yamakawa Chemical Ind | Verfahren zur Herstellung von optisch aktiven Piperazinderivaten und Zwischenprodukten für ihre Herstellung |
| CA2186483A1 (en) * | 1995-02-03 | 1996-08-08 | Akira Nishiyama | Processes for producing .alpha.-halo ketones, .alpha.-halohydrins and epoxides |
| US5618937A (en) * | 1995-03-15 | 1997-04-08 | Merck & Co., Inc. | Process to make HIV protease inhibitor from (2S)-4-picolyl-2-piperazine-t-butylcarboxamide |
| CA2179935C (en) * | 1995-06-30 | 2010-09-07 | Ryohei Kato | Novel dipeptide compound or pharmaceutically acceptable salt thereof and medical use thereof |
| US6222043B1 (en) | 1995-06-30 | 2001-04-24 | Japan Energy Corporation | Methods of preparing novel dipeptide compounds or pharmaceutically acceptable salts thereof |
| PT984000E (pt) * | 1995-09-26 | 2009-02-06 | Agouron Pharma | Processo para a produção de derivados amina e compostos intermediários |
| US6133461A (en) | 1995-09-26 | 2000-10-17 | Japan Tobacco Inc. | Process for producing amide derivatives and intermediates therefor |
| ES2293651T3 (es) * | 1995-11-28 | 2008-03-16 | Cephalon, Inc. | Inhibidores de cisteina y serina proteasas derivados de aminoacidos d. |
| US5962725A (en) | 1996-09-05 | 1999-10-05 | Agouron Pharmaceuticals, Inc. | Intermediate compounds useful for making HIV protease inhibitors such as nelfinavir |
| WO1998029118A1 (en) | 1996-12-27 | 1998-07-09 | Japan Energy Corporation | Novel tripeptide compounds and anti-aids drugs |
| JP4006058B2 (ja) | 1997-03-11 | 2007-11-14 | 第一三共株式会社 | 多臓器不全予防及び／又は治療剤 |
| DE69836315T2 (de) | 1997-03-14 | 2007-05-31 | Daiichi Pharmaceutical Co., Ltd. | Verwendung von TCF-II zur Behandlung von durch Krebs verursachtem Gewichtsverlust, Anaemie und TNF-Erhöhung |
| WO2000002862A1 (en) * | 1998-07-08 | 2000-01-20 | G.D. Searle & Co. | Retroviral protease inhibitors |
| NZ525513A (en) | 1998-08-07 | 2004-09-24 | Pont Pharmaceuticals Du | Succinoylamino lactams as inhibitors of Abeta protein production |
| HRP990246A2 (en) | 1998-08-07 | 2000-06-30 | Du Pont Pharm Co | Succinoylamino benzodiazepines as inhibitors of a beta protein production |
| CN1636011A (zh) * | 1998-12-24 | 2005-07-06 | 杜邦药品公司 | 作为Aβ蛋白产生抑制剂的琥珀酰氨基苯并二氮杂䓬 |
| US6503902B2 (en) | 1999-09-13 | 2003-01-07 | Bristol-Myers Squibb Pharma Company | Hydroxyalkanoylaminolactams and related structures as inhibitors of a β protein production |
| US6960576B2 (en) * | 1999-09-13 | 2005-11-01 | Bristol-Myers Squibb Pharma Company | Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production |
| EP1218377A1 (en) | 1999-10-08 | 2002-07-03 | Bristol-Myers Squibb Pharma Company | AMINO LACTAM SULFONAMIDES AS INHIBITORS OF A$g(b) PROTEIN PRODUCTION |
| AU2001239791A1 (en) | 2000-02-17 | 2001-08-27 | Du Pont Pharmaceuticals Company | Succinoylamino carbocycles and heterocycles as inhibitors of abeta protein production |
| US6495540B2 (en) | 2000-03-28 | 2002-12-17 | Bristol - Myers Squibb Pharma Company | Lactams as inhibitors of A-β protein production |
| AU2001253090A1 (en) | 2000-04-03 | 2001-10-15 | Bristol-Myers Squibb Pharma Company | Cyclic lactams as inhibitors of abeta protein production |
| JP2004508289A (ja) | 2000-04-03 | 2004-03-18 | デュポン ファーマシューティカルズ カンパニー | Ａβタンパク質産生の阻害剤としての環状ラクタム |
| JP2004500419A (ja) * | 2000-04-11 | 2004-01-08 | デュポン ファーマシューティカルズ カンパニー | Ａβタンパク質産生阻害剤としての置換ラクタム |
| US20100009966A1 (en) * | 2001-04-11 | 2010-01-14 | Bristol-Myers Squibb Pharma Company | Substituted lactams as inhibitors of abeta protein production |
| AU2001261728A1 (en) * | 2000-05-17 | 2001-11-26 | Bristol-Myers Squibb Pharma Company | Use of small molecule radioligands for diagnostic imaging |
| AU783857B2 (en) | 2000-06-01 | 2005-12-15 | Bristol-Myers Squibb Pharma Company | Lactams substituted by cyclic succinates as inhibitors of a beta protein production |
| GB0028483D0 (en) * | 2000-11-22 | 2001-01-10 | Hoffmann La Roche | Hydroxyethylamine HIV protease inhibitors |
| JPWO2002064553A1 (ja) * | 2001-02-14 | 2004-06-10 | 呉羽化学工業株式会社 | ハロゲノアルコール誘導体の製造方法 |
| US20090062256A1 (en) * | 2001-06-01 | 2009-03-05 | Bristol-Myers Squibb Pharma Company | LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Abeta PROTEIN PRODUCTION |
| GB0123467D0 (en) | 2001-09-28 | 2001-11-21 | Hoffmann La Roche | Carbocyclic HIV Protease inhibitors |
| KR101155335B1 (ko) * | 2005-01-07 | 2012-06-11 | 엘지전자 주식회사 | 이동통신 단말기의 멀티미디어 메시지 동작방법 |
| ES2426345T3 (es) | 2005-07-20 | 2013-10-22 | Eli Lilly And Company | Compuesto unidos en posición 1-amino |
| CN101508664B (zh) * | 2009-02-25 | 2012-08-22 | 江阴希迪医药科技有限公司 | N-苄氧羰基-3-氨基-1-氯-4-苯硫基-2-丁醇合成方法 |
| PH12013500015A1 (en) | 2010-07-02 | 2013-02-18 | Gilead Sciences Inc | 2 -quinolinyl- acetic acid derivatives as hiv antiviral compounds |
| US9102614B2 (en) * | 2010-07-02 | 2015-08-11 | Gilead Sciences, Inc. | Naphth-2-ylacetic acid derivatives to treat AIDS |
| EA024952B1 (ru) | 2011-04-21 | 2016-11-30 | Джилид Сайэнс, Инк. | Бензотиазолы и их применение для лечения вич-инфекции |
| US9284323B2 (en) | 2012-01-04 | 2016-03-15 | Gilead Sciences, Inc. | Naphthalene acetic acid derivatives against HIV infection |
| US9376392B2 (en) | 2012-01-04 | 2016-06-28 | Gilead Sciences, Inc. | 2-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS |
| RU2014115227A (ru) | 2012-04-20 | 2015-10-27 | Джилид Сайэнс, Инк. | Производные бензотиазол-6-ил уксусной кислоты и их примение для лечения вич-инфекции |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5142056A (en) * | 1989-05-23 | 1992-08-25 | Abbott Laboratories | Retroviral protease inhibiting compounds |
| IL89900A0 (en) * | 1988-04-12 | 1989-12-15 | Merck & Co Inc | Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them |
| CA1340588C (en) | 1988-06-13 | 1999-06-08 | Balraj Krishan Handa | Amino acid derivatives |
| EP0361341A3 (en) * | 1988-09-28 | 1991-07-03 | Miles Inc. | Therapeutics for aids based on inhibitors of hiv protease |
| GB8927913D0 (en) * | 1989-12-11 | 1990-02-14 | Hoffmann La Roche | Amino acid derivatives |
| DE69133464T2 (de) | 1990-11-19 | 2006-05-18 | Pharmacia Corp.(N.D.Ges.D.Staates Delaware) | Retrovirusprotease Inhibitoren |
| AU647239B2 (en) * | 1991-02-08 | 1994-03-17 | Sankyo Company Limited | New beta-amino- alpha-hydroxycarboxylic acids and their use |
| US5430041A (en) * | 1991-05-10 | 1995-07-04 | Hoffmann-La Roche Inc. | Amino acid derivatives having antiviral activity |
| CN1071930A (zh) * | 1991-07-10 | 1993-05-12 | 伊莱利利公司 | 用作治疗艾滋病的人免疫缺陷病毒蛋白酶的抑制剂 |
| WO1993013066A1 (en) | 1991-12-20 | 1993-07-08 | Syntex (U.S.A.) Inc. | Cyclic amides of 3-amino-2-hydroxy-carboxylic acids as hiv-protease inhibitors |
| US5312820A (en) * | 1992-07-17 | 1994-05-17 | Merck & Co., Inc. | Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines |
-
1993
- 1993-12-15 MX MX9308016A patent/MX9308016A/es not_active IP Right Cessation
- 1993-12-17 CZ CZ932814A patent/CZ281493A3/cs unknown
- 1993-12-17 NZ NZ250491A patent/NZ250491A/en unknown
- 1993-12-17 MY MYPI93002745A patent/MY131388A/en unknown
- 1993-12-20 AT AT93310359T patent/ATE178055T1/de not_active IP Right Cessation
- 1993-12-20 NO NO934719A patent/NO934719L/no unknown
- 1993-12-20 DE DE69324120T patent/DE69324120T2/de not_active Expired - Fee Related
- 1993-12-20 PL PL93301581A patent/PL301581A1/xx unknown
- 1993-12-20 HU HU9303679A patent/HUT69693A/hu unknown
- 1993-12-20 EP EP93310359A patent/EP0604185B1/en not_active Expired - Lifetime
- 1993-12-20 ES ES93310359T patent/ES2132201T3/es not_active Expired - Lifetime
- 1993-12-20 AU AU52528/93A patent/AU667146B2/en not_active Ceased
- 1993-12-20 IL IL108092A patent/IL108092A/en active IP Right Grant
- 1993-12-21 BR BR9305162A patent/BR9305162A/pt not_active Application Discontinuation
- 1993-12-21 CA CA002112042A patent/CA2112042A1/en not_active Abandoned
- 1993-12-21 FI FI935778A patent/FI935778A7/fi not_active Application Discontinuation
- 1993-12-21 CN CN93112962A patent/CN1044117C/zh not_active Expired - Fee Related
- 1993-12-21 JP JP5322750A patent/JPH06271534A/ja active Pending
- 1993-12-22 KR KR1019930029121A patent/KR940014337A/ko not_active Abandoned
- 1993-12-22 TW TW082110893A patent/TW262468B/zh active
-
1997
- 1997-11-19 US US08/974,430 patent/US5905077A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0604185B1 (en) | 1999-03-24 |
| CN1044117C (zh) | 1999-07-14 |
| HUT69693A (en) | 1995-09-28 |
| CZ281493A3 (en) | 1994-07-13 |
| NO934719D0 (no) | 1993-12-20 |
| FI935778A0 (fi) | 1993-12-21 |
| AU5252893A (en) | 1994-07-07 |
| DE69324120T2 (de) | 1999-11-25 |
| MX9308016A (es) | 1994-08-31 |
| FI935778A7 (fi) | 1994-06-23 |
| ES2132201T3 (es) | 1999-08-16 |
| CA2112042A1 (en) | 1994-06-23 |
| TW262468B (OSRAM) | 1995-11-11 |
| DE69324120D1 (de) | 1999-04-29 |
| NZ250491A (en) | 1995-08-28 |
| JPH06271534A (ja) | 1994-09-27 |
| CN1094399A (zh) | 1994-11-02 |
| PL301581A1 (en) | 1994-06-27 |
| US5905077A (en) | 1999-05-18 |
| KR940014337A (ko) | 1994-07-18 |
| IL108092A0 (en) | 1994-04-12 |
| IL108092A (en) | 1998-06-15 |
| AU667146B2 (en) | 1996-03-07 |
| ATE178055T1 (de) | 1999-04-15 |
| EP0604185A1 (en) | 1994-06-29 |
| BR9305162A (pt) | 1994-11-01 |
| MY131388A (en) | 2007-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO934719L (no) | Hemmere av HIV-protease som er nyttige for behandling av AIDS | |
| NO954427L (no) | Hiv-proteaseinhibitorer som er anvendbare for behandling av AIDS | |
| FI905983A0 (fi) | Aminosyraderivat. | |
| NO176356C (no) | Analogifremgangsmåte for fremstilling av nye terapeutisk aktive pyrazolopyridinforbindelser | |
| DZ1694A1 (fr) | "n-(2-Aminoethyl)-benzothialozones". | |
| NO983992L (no) | Serinprotease inhibitorer | |
| NO934721L (no) | Hemmere av HIV-protease som er nyttige for behandling av AIDS | |
| NO983991L (no) | Serin-protease-inhibitorer | |
| DK163581C (da) | Kondenserede pyrazol-3-oxo-propannitrilderivater og fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende forbindelserne | |
| EE9600045A (et) | 5,6-dihüdropüranooni derivaadid kui proteaasi inhibiitorid ja viirusevastased toimeained | |
| YU67792A (sh) | Inhibitori hiv proteaze korisni za lečenje aids | |
| ATE74138T1 (de) | Heptanoyl-glu-asp-ala-amino-saeureimmunstimulanten. | |
| DE3778642D1 (de) | Therapeutikum zur behandlung von magengeschwueren. | |
| NO174886C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive pyrrolidin-derivater | |
| DK0383635T3 (da) | Peptider med renin-inhiberende virkning samt deres fremstilling og anvendelse | |
| RU2003105827A (ru) | Средства против слабоумия, содержащие производные 2-арил-8-оксодигидропурина, в качестве активного ингредиента | |
| TH32445A (th) | สารยับยั้งเซรีนโปรทีเอส | |
| MY111630A (en) | Amino acid derivatives. | |
| EP0389178A3 (en) | Acrylamido-penicillanic-acid derivatives |